إعلان
إعلان
GYRE
Gyre Therapeutics, Inc. Common Stock
7.41
USDبرعاية
-0.16
-2.11%
٠٩ يناير, ١٥:٥٧ UTC -5
مغلق
بعد الإغلاق
7.41
0.00
0.00%
تقارير أرباح GYRE
النسبة الإيجابية المفاجئة
GYRE تفوق 16 من 33 آخر التقديرات.
48%
التقرير التالي
بيانات التقرير القادم
١٨ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$37.03M
/$0.05
التغير الضمني من Q3 25 (Revenue/ EPS)
+21.15%
/-37.50%
التغير الضمني من Q4 24 (Revenue/ EPS)
+32.86%
/--
Gyre Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, GYRE reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of 0.02 USD, resulting in a 194.12% surprise. Revenue reached 30.56 مليون, compared to an expected 33.59 مليون, with a -9.00% difference. The market reacted with a -1.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of 0.05 USD, with revenue projected to reach 37.03 مليون USD, implying an نقصان of -37.50% EPS, and زيادة of 21.15% in Revenue from the last quarter.
الأسئلة الشائعة
What were Gyre Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gyre Therapeutics, Inc. Common Stock reported EPS of $0.08, beating estimates by 194.12%, and revenue of $30.56M, -9% below expectations.
How did the market react to Gyre Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.77%, changed from $7.34 before the earnings release to $7.21 the day after.
When is Gyre Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٨ فبراير ٢٠٢٦.
What are the forecasts for Gyre Therapeutics, Inc. Common Stock's next earnings report?
Based on 5
المحللين, Gyre Therapeutics, Inc. Common Stock is expected to report EPS of $0.05 and revenue of $37.03M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان